Lyonbiopole Auvergne-Rhône-Alpes

Lyonbiopole Auvergne-Rhône-Alpes was accredited as a competitiveness cluster when it was created and is the driver of the health innovation ecosystem in Auvergne-Rhône-Alpes, ensuring that it is connected, developed and promoted.

Discover Lyonbiopole

Lyonbiopole launches its Jobboard

For companies to submit their job offers and look for talent, and candidates to post their CV and find a job.

Lyonbiopole launches its Jobboard

For companies to submit their job offers and look for talent, and candidates to post their CV and find a job.

Lyonbiopole launches its Jobboard

For companies to submit their job offers and look for talent, and candidates to post their CV and find a job.

Virtual Health Jobdating

June 9 and 10, 2022 : an event organized by Lyonbiopole with the support of the Auvergne-Rhône-Alpes Region

Virtual Health Jobdating

June 9 and 10, 2022 : an event organized by Lyonbiopole with the support of the Auvergne-Rhône-Alpes Region

Virtual Health Jobdating

June 9 and 10, 2022 : an event organized by Lyonbiopole with the support of the Auvergne-Rhône-Alpes Region

Our services

Lyonbiopole advises and works with more than 270 members, companies, academics and hospitals in the Auvergne-Rhône-Alpes region, for their innovation, growth or hosting projects.

Innovate

Lyonbiopole’s experience and expertise help to build new public-private partnerships and enable R&D projects to mature in order to accelerate the development of innovative products, technologies and services that meet current and future health challenges.

Learn more

Develop

Lyonbiopole helps its members grow, from their strategies to financing, human resources, international development, and communication.

Discover

Host

Lyonbiopole provides innovators with flexible P2 and P3 R&D laboratories with shared spaces.

Discover

Integrated into the community

Lyonbiopole brings together and leads the regional health network of key members in scientiﬁc, technological and medical innovation: public authorities and local government, academics and university staff, hospitals and industry workers.

An ecosystem
of excellence Lyonbiopole's
members directory network of
international partners

Do not miss

All events

News

oct. 4^th, 2023

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

Combining expertise in the research of new phages and phage endolysins that could be applied to human health

oct. 4^th, 2023

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

Combining expertise in the research of new phages and phage endolysins that could be applied to human health

oct. 4^th, 2023

PHAXIAM Therapeutics and Vetophage Announce Strategic Research Collaboration

Combining expertise in the research of new phages and phage endolysins that could be applied to human health

sept. 19^th, 2023

PHAXIAM Therapeutics extends its phage portfolio

to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

sept. 19^th, 2023

PHAXIAM Therapeutics extends its phage portfolio

to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

sept. 19^th, 2023

PHAXIAM Therapeutics extends its phage portfolio

to Klebsiella pneumoniae, a new resistant and aggressive bacterial target

sept. 18^th, 2023

Harvard Bioscience and Etisense Announce Agreement

For Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

sept. 18^th, 2023

Harvard Bioscience and Etisense Announce Agreement

For Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

sept. 18^th, 2023

Harvard Bioscience and Etisense Announce Agreement

For Supply and Distribution of DECRO Miniature Telemetry Jacket Platform for Pre-Clinical Research

sept. 18^th, 2023

Carthera appoints Dr. Oern Stuge as chairman of board of directors

Medical device industry executive with 30+ years expertise brings wealth of experience in product development and commercial launches to support Carthera’s future growth

sept. 18^th, 2023

Carthera appoints Dr. Oern Stuge as chairman of board of directors

Medical device industry executive with 30+ years expertise brings wealth of experience in product development and commercial launches to support Carthera’s future growth

sept. 18^th, 2023

Carthera appoints Dr. Oern Stuge as chairman of board of directors

Medical device industry executive with 30+ years expertise brings wealth of experience in product development and commercial launches to support Carthera’s future growth

sept. 12^th, 2023

Valbiotis presents the full results of the Phase II/III REVERSE-IT study

Impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes, a first for a non-drug active substance

sept. 12^th, 2023

Valbiotis presents the full results of the Phase II/III REVERSE-IT study

Impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes, a first for a non-drug active substance

sept. 12^th, 2023

Valbiotis presents the full results of the Phase II/III REVERSE-IT study

Impressive efficacy of TOTUM•63 against prediabetes and the early stages of type 2 diabetes, a first for a non-drug active substance

All news

Log in

Lyonbiopole provides its members with additional content and information that can only be accessed by being connected to the site.

Lyonbiopole

COMMUNITY spirit: we bring together a real community within our region, to help the whole ecosystem. This collaborative spirit also encompasses our internal team.

Fully COMMITTED: we are determined to support our members, collectively and individually, meeting their needs as closely as possible to help them progress and innovate.

Taking INITIATIVE: our expert team specialises in various fields and works on a wide range of issues in an agile, pragmatic way to respond to demand.

Missions Team Contact

270

Members

228

SME Members

193

R&D projects supported

85

Organized events

500

Relayed job offers

218

M€ raised by our members